Ephraim Lindenbaum is a founder and Managing Director of Advance Ventures, a Silicon Valley-based venture investment fund and venture accelerator that invests in seed and early-stage start-ups across three core sectors; Sustainability (AgTech, CleanTech, FoodTech) Communications (Mobility & IoT) and Information Technology (Enterprise & Verticals: DigitalHealth, FinTech). Founded in 1999, Advance Ventures has consistently achieved meaningful exits with its portfolio companies across its core market sectors.
Mr. Lindenbaum has served as a board member, board advisor and/or investor: Alpha Foods, Acerro, Agnitia Networks (acquired by LeadingEdge), BonTriage, BPG Worldwide, Bright Light Systems, Corvigo (acquired by NASDAQ: TMWD), eSports (acquired by Ositech), EVAOS, Front Range Biosciences, Grazix, iLoopMobile (acquired by Archer), Inertia Beverage Group (now WineDirect), Kite.io (acquired by Quixey) LandSonar (acquired by Triangle) MerchEngines (acquired by NASDAQ: DLX) MycoTechnology, Ooba Beverages (acquired by HealthyBrands), Parago (acquired by NASDAQ: HAWK) Realta, Sitebase, SkillGigs, Smaato (acquired by Spearhead), SnapMD, Solaireo, TerraFusion, Tunewear, Workout.com and YouVoice.
Prior to founding Advance Ventures, Mr. Lindenbaum was the co-founder of interactive media pioneer Broadcast Production Group and served as CEO until its acquisition in 1999 by Parago (acquired by NASDAQ: HAWK), a leading global financial engagement management company.
Dov Szapiro is Co-Founder, Managing Partner & Principal of Entourage Effect Capital. Together with the other co-Founders of the firm, Mr. Szapiro is responsible for overseeing the firm’s strategy, governance, and business operations in partnership with the executive team. He is also responsible for overseeing the day-to-day operations of the firm in tandem to shepherding the Fund’s portfolio companies looking to exit. He has more than 20 years of experience as a senior executive, investor, advisor and board member in companies across multiple industries and different growth phases.
Jon Trauben is a partner in Altitude Investment Management. Altitude is a cannabis-focused investment fund that invests across the domestic and international cannabis industry. Jon is a cannabis investor, association member, mentor and board member to several of his funds’ portfolio companies. He brings a wealth of experience and management expertise with a 25-year record as a seasoned commercial real estate, capital markets, and finance executive. Jon has held senior positions on Wall Street while at Barclays, Credit Suisse, Cantor Fitzgerald and Hunt Companies where he was a business leader, lender, trader and investor.
Dr. Ramie A. Tritt is a physician entrepreneur whose 40 year investment career has involved leadership roles in private and public companies in multiple industries, including healthcare. Over the past six years Dr. Tritt has founded and managed two cannabis investment funds, most recently as Managing Principal of The Panther Opportunity Fund; and in total has invested in 25+ companies in all sectors of the cannabis industry. Dr. Tritt sits on the boards of multiple cannabis and non-cannabis companies providing critical advice to hypergrowth focused companies.
Dr. Michael Hogan is an expert in the microarray field. Prior he was Co-Founder and CSO of GMSbiotech, and he has founded three companies that were funded by first-tier venture capital in oligonucleotide therapeutics, microarray and applied genomics arena. Dr. Hogan has had extensive interaction with the U.S. Food and Drug Administration and other relevant government agencies. He has 27 years experience in the area of physical biochemistry. He founded and co-founded five additional companies in the biotechnology and biopharma arena including Triplex Pharmaceutical (antisense and antigene oligonucleotide technology) and Genometrix, Inc., (DNA microarray services & technology).
Milan has over 25 years of experience with large public, to small private and entrepreneurial companies in numerous industries from life sciences, biotechnology, government services and automotive. Previously, Milan Patel was COO/CFO of GMSbiotech. He also was CFO of 2020 Company, LLC -a leading premier professional services firm that delivered business and technology solutions to the government, in the areas of health, education and science.